Literature DB >> 2224146

Transient pancytopenia. A report from the International Agranulocytosis and Aplastic Study.

M Keisu1, W Heit, G Lambertenghi-Deliliers, J Parcells-Kelly, A Polliack, H Heimpel.   

Abstract

From a population-based study on the incidence of potentially drug-associated blood dyscrasias 28 cases were identified with pancytopenia. Who recovered within 90 days after diagnosis. Early recovery occurred more frequently in patients showing normal or increased cellularity of the bone marrow than in patients with bone marrow hypoplasia. Median recovery times of leukocytes were 14 and 10 days and of platelets 21 and 9 days in patients with and without bone marrow hypoplasia, respectively. Age and sex distribution were similar in both groups. Of 28 patients, 11 reported a period of fever before onset of pancytopenia. Sixteen patients in whom information on drug use was available had taken a median of 4 drugs before the onset of symptoms that were related to pancytopenia. From these results we present the hypothesis that transient pancytopenia with or without marrow hypoplasia can be the expression of the same type of bone marrow injury and that drugs or viral infections should be considered as etiological factors.

Entities:  

Mesh:

Year:  1990        PMID: 2224146     DOI: 10.1007/bf01744138

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  29 in total

1.  Methyprylon-induced bone marrow suppression in siblings. An inherited defect?

Authors:  G D McLaren; M A Doukas; W A Muir
Journal:  JAMA       Date:  1978-10-13       Impact factor: 56.272

Review 2.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis.

Authors:  W Heit; H Heimpel; A Fischer; N Frickhofen
Journal:  Scand J Haematol       Date:  1985-11

4.  Quinidine-sulfate-induced hypoplastic anemia and agranulocytosis.

Authors:  U S Barzel
Journal:  JAMA       Date:  1967-07-31       Impact factor: 56.272

5.  Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.

Authors: 
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

6.  Neutropenia after penicillins: toxic or immune-mediated?

Authors:  K A Neftel; M Wälti; H Spengler; A von Felten; S A Weitzman; H Bürgi; A L de Weck
Journal:  Klin Wochenschr       Date:  1981-08-17

7.  Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics.

Authors:  K A Neftel; S P Hauser; M R Müller
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

8.  Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.

Authors:  P C Vincent
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

9.  Procainamide-induced agranulocytosis and thrombocytopenia.

Authors:  I K Rothman; E L Amorosi
Journal:  Arch Intern Med       Date:  1979-02

10.  Agranulocytosis during treatment with chlozapine.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I P Palva
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

View more
  2 in total

Review 1.  Acquired aplastic anemia in children: incidence, prognosis and treatment options.

Authors:  Anna Locasciulli
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Cobalamin and folic Acid status in relation to the etiopathogenesis of pancytopenia in adults at a tertiary care centre in north India.

Authors:  M Premkumar; N Gupta; T Singh; T Velpandian
Journal:  Anemia       Date:  2012-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.